• About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact

10 News First reports Ellume’s $42M NIH funding for rapid COVID test

8 October 2020, Samantha Butler

Ellume Founder, CEO and Managing Director Dr Sean Parsons was recently interviewed by 10 News First Queensland’s Samantha Butler on the successful awarding of $42m from the US NIH to Ellume to scale up and fast track the production of its COVID-19 diagnostic tests.

This interview originally appeared on 10 News First Queensland TV news on 8th October 2020. The story can also be viewed on on the 10 Play app.

Recent Posts
  • Ellume founder Dr Parsons on COVID testing, Omicron
  • Ellume named Popular Science Best of What’s New 2021
  • Ellume wins AFR BOSS Most Innovative Company Award
  • QIAGEN receives U.S. FDA emergency use authorization for rapid portable SARS-CoV-2 antigen test
  • Push to allow at-home COVID tests in Australia
Archives
Categories
Business

Ellume awarded US$30M from US National Institutes of Health RADx initiative to accelerate development of rapid COVID-19 diagnostics

Previous thumb

Ellume enlists Bosch Australia to automate manufacturing for high-performance COVID-19 Test

Next thumb
Scroll
ellume logo white
Menu

Home
About Us
COVID-19 Response
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
News

Quick Links

Contact Us
Terms of Use
Privacy Policy
Whistleblower Policy

Some products pending regulatory clearance and not available for sale. © Ellume Limited 2022
ABN 13 141 767 660